CD74–ROS1 L2026M mutant enhances autophagy through the MEK / ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells

Ähnliche Einträge

• EML4‐ALK G1202R and EML4‐ALK L1196M mutations induce crizotinib resistance in non‐small cell lung cancer cells through activating epithelial–mesenchymal transition mediated by MDM2/MEK/ERK signal axis
  von: Yuying Yang, et al.
  Veröffentlicht: (2024)
• The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib
  von: Anil Kumar Mondru, et al.
  Veröffentlicht: (2024)
• LC3 ‐positive extracellular vesicles released from tumor cells promote lung metastasis of breast cancer by inducing vascular permeability
  von: Yuqing Shen, et al.
  Veröffentlicht: (2025)
• Gal‐1 promotes lung cancer cell survival by enhancing PARP1 / H1 .2 interaction to promote DNA repair upon DNA damage response
  von: Yihao Chen, et al.
  Veröffentlicht: (2025)
• Stromagenesis and cancer‐associated fibroblast heterogeneity in primary tumors and metastasis: focus in non‐small cell lung cancer
  von: Alejandro Bernardo, et al.
  Veröffentlicht: (2025)